Leading a Novel Approach to Targeting the Microbiome

Kaleido Biosciences is a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health.
icon2

Discovery & Development Model

Enables rapid advancement into human clinical studies

Learn about our proprietary product platform

icon3

Broad Pipeline

Candidates addressing a variety of diseases and conditions with high unmet needs

View our pipeline

icon4

Exceptional Team

Committed to scientific innovation, transforming lives and fostering a strong culture

Join the team